application - International Pharmaceutical Industry

Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...

13 January 2023 Volume 14 Issue 4 application | approval

Continue Reading →

News

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive...

17 July 2018 News AbbVie | announces

Continue Reading →

News

Brussels Airport launches blockchain application on their winning BRUcloud data sharing platform

Last month, during the Air China Cargo exhibition in Shanghai, Brussels Airport and their cargo community won the award for “IT solution of the year” with BRUclo...

14 June 2018 News airport | application

Continue Reading →

News

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Invivoscribe Technologies, Inc. announced today that they have submitted to Japan's Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Adminis...

8 May 2018 News application | approval

Continue Reading →

News

Starpharma completes US New Drug Application for VivaGel BV

VivaGel BV stands to be the first and only product approved for the prevention of recurrent BV Australian pharma giant Starpharma today announced that its rollin...

1 May 2018 News application | BV

Continue Reading →

News

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved. Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd...

23 January 2018 News application | approval

Continue Reading →

News

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Elpis BioMed Ltd (Elpis), a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell reprogramming” platform to produce pure, mature an...

20 November 2017 News application | cell

Continue Reading →

Regulatory & Marketplace v4i3

Extending Your Patent on a New Application for an Old Drug

Extending Your Patent on a New Application for an Old Drug The period that is necessary to obtain a marketing authorisation to bring a n...

28 September 2012 Regulatory & Marketplace v4i3 | Volume 4 Issue 3 application | drug

Continue Reading →

SCHOTT Pharma

Integrated Product Development by PharmaLex

It’s All About Stem Cells

Covid 19

Current Edition

At last! The Advent of Better Software Application UX to Manage Critical Manufacturing Processes in Highly Regulated Industries

EU CTR: Final Countdown, What You Need to Know

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

Brussels Airport launches blockchain application on their winning BRUcloud data sharing platform

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Starpharma completes US New Drug Application for VivaGel BV

Wickham Laboratories Holdings Announces Planning Application Approval

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Extending Your Patent on a New Application for an Old Drug

International Pharmaceutical Industry